Browsing: Lacaze

Market Trends

Robert Lacaze joins Summit Therapeutics as chief commercial officer

By admin8996erT0allMarch 17, 2025

Summit Therapeutics (NASDAQ:SMMT) has appointed Robert LaCaze as chief commercial officer, reporting to Manmeet S. Soni, chief operating officer and chief financial…

What's Hot

FinVolution Group hikes annual dividend by 16.9% to $0.277

Lithium Americas GAAP EPS of -$0.09; initiates FY25 outlook

Galiano Gold Non-GAAP EPS of $0.02, revenue of $64.55M

Browsing: Lacaze

Robert Lacaze joins Summit Therapeutics as chief commercial officer

Top Insights

FinVolution Group hikes annual dividend by 16.9% to $0.277

Lithium Americas GAAP EPS of -$0.09; initiates FY25 outlook

Galiano Gold Non-GAAP EPS of $0.02, revenue of $64.55M